Orphan nuclear receptor NR2E3 is a new molecular vulnerability in solid tumors by activating p53
Abstract The orphan nuclear receptor NR2E3 has emerged as a potential tumor suppressor, yet its precise mechanisms in tumorigenesis require further investigation. Here, we demonstrate that the full-length protein isoform of NR2E3 instead of its short isoform activates wild-type p53 and is capable of...
Saved in:
Main Authors: | Yidan Wang, Todd G. Kroll, Linhui Hao, Zhi Wen |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2025-01-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-025-07337-1 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Orphan Nuclear Receptor 4A1: A Potential New Therapeutic Target for Metabolic Diseases
by: Lei Zhang, et al.
Published: (2018-01-01) -
Regulation of NK cell development, maturation, and antitumor responses by the nuclear receptor NR2F6
by: Johannes Woelk, et al.
Published: (2025-02-01) -
The Major Prognostic Features of Nuclear Receptor NR5A2 in Infiltrating Ductal Breast Carcinomas
by: Li-Yun Chang, et al.
Published: (2015-01-01) -
Mina53 catalyzes arginine demethylation of p53 to promote tumor growth
by: Lixiao Zhou, et al.
Published: (2025-02-01) -
Chemogenomics for steroid hormone receptors (NR3)
by: Espen Schallmayer, et al.
Published: (2025-02-01)